Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1633
This examiner grants 47% of resolved cases
James J. Graber serves as an examiner in Tech Center 1600, Art Unit 1631. With 196 resolved cases, his profile shows an allowance rate of 46.4 percent. This rate indicates a moderate level of difficulty, where just under half of the applications are successfully patented.
The interview lift is a substantial 57.5 percent. This is a critical data point, as it suggests that interviews are incredibly effective at changing the outcome of a case. For an applicant facing the 46.4 percent baseline allowance rate, the lift from an interview represents a major strategic advantage that should be utilized in almost every instance.
The median time to allowance is 1389 days. This timeline is typical for the biological and chemical arts in Tech Center 1600. The 196 resolved cases highlight a clear pattern: while the baseline success rate is moderate, the 57.5 percent interview lift makes direct communication the most powerful tool available to practitioners in Art Unit 1631.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18558859 | UNIVERSAL RETARGETING OF ONCOLYTIC HSV | Non-Final OA | Janssen Biotech, Inc. |
| 18680912 | Methods of Producing Astrocytes or Promoting Astrocyte Development and Cell Culture Compositions Related Thereto | Non-Final OA | Emory University |
| 18289881 | 3D HUMAN DISTAL LUNG ORGANOIDS CONTAINING EPITHELIAL, IMMUNE AND MESENCHYMAL COMPONENTS | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18568091 | METHODS FOR ENGINEERING AND USE OF CILIATED ORGANOIDS HAVING NATIVE-LIKE, APICAL-OUT POLARITY | Non-Final OA | Carnegie Mellon University |
| 18248193 | PRODUCTION OF MEGAKARYOCYTES AND PLATELETS IN A CO-CULTURE SYSTEM | Final Rejection | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17580219 | INCREASING GENOME STABILITY AND REPROGRAMMING EFFICIENCY OF INDUCED PLURIPOTENT STEM CELLS | Final Rejection | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 17911018 | COMPOSITION FOR INDUCING APOPTOSIS OF CELLS HAVING GENOMIC SEQUENCE VARIATION AND METHOD FOR INDUCING APOPTOSIS OF CELLS BY USING COMPOSITION | Final Rejection | UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) |
| 18547332 | Compositions For and Methods of Improving Gene Therapy | Non-Final OA | Duke University |
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | Final Rejection | DUKE UNIVERSITY |
| 17258533 | USE OF IL-12 TO ALTER EPIGENETIC EFFECTOR PROGRAMS IN CD8 T CELLS | Final Rejection | St. Jude Children's Research Hospital |
| 18170671 | PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED NATURAL KILLER CELLS AND ANTIGEN-SPECIFIC T CELLS, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME | Final Rejection | NATIONAL YANG MING CHIAO TUNG UNIVERSITY |
| 18567094 | COMPOSITIONS AND METHODS FOR ISLET CELL TRANSPLANTS | Final Rejection | City of Hope |
| 18682797 | GENETICALLY MODIFIED CELLS FOR ALLOGENEIC CELL THERAPY TO REDUCE INSTANT BLOOD MEDIATED INFLAMMATORY REACTIONS | Non-Final OA | Sana Biotechnology, Inc. |
| 18704322 | METHOD FOR PRODUCING ORGANISM, AND METHOD FOR PROMOTING DIFFERENTIATION OF HUMAN ADIPOSE-DERIVED STEM CELLS INTO VASCULAR ENDOTHELIAL CELLS | Final Rejection | KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION |
| 18517402 | METHOD FOR PREPARING BROWN ADIPOCYTE | Non-Final OA | KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy